Cognitive Impairment Associated with Schizophrenia: a Review of the Humanistic Burden

被引:56
|
作者
Kitchen, Helen [1 ]
Rofail, Diana
Heron, Louise
Sacco, Pat [2 ]
机构
[1] Adelphi Mill, Adelphi Values, Bollington SK10 5JB, Cheshire, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
关键词
burden; cognitive impairment associated with schizophrenia; conceptual model; cost; humanistic; patient reported outcome; schizophrenia; QUALITY-OF-LIFE; ANTIPSYCHOTIC MEDICATIONS; 2ND-GENERATION ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; ATYPICAL ANTIPSYCHOTICS; EXECUTIVE FUNCTION; NEGATIVE SYMPTOMS; ECONOMIC BURDEN; UNITED-STATES;
D O I
10.1007/s12325-012-0001-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (CIAS); (b) develop a conceptual model that depicts the signs and symptoms of CIAS along with key concepts important to patients; and (c) consider the adequacy of potential patient-reported outcome (PRO) instruments for assessing future treatments. Methods: The following electronic databases were searched for articles published between January 1999 and November 2009 related to CIAS and PROs, or cost of illness: Medline; Embase; PsycINFO; the Health Economic Evaluation Database; and the National Health Service Economic Evaluation Database and Health Technology Assessment databases at the Centre for Reviews and Dissemination, University of York. Results: The literature search revealed 3950 abstracts, of which 101 articles were reviewed in detail. Cognitive functions affected include memory, attention/concentration, problem solving, learning, executive function, processing speed, and social cognition. Cognitive impairment impacts the ability of individuals to carry out activities of daily living, work productively, function socially, and adhere to treatment. These effects have economic ramifications through increased direct and indirect costs associated with the treatment of schizophrenia. The literature revealed 39 PRO instruments that have been used to assess functioning. However, no single instrument captures all key concepts of importance to patients with schizophrenia. Conclusion: The significant burden from CIAS for patients and society has implications for designing future treatments and health strategies to improve functional outcomes.
引用
收藏
页码:148 / 162
页数:15
相关论文
共 50 条
  • [1] Cognitive Impairment Associated with Schizophrenia: A Review of the Humanistic Burden
    Helen Kitchen
    Diana Rofail
    Louise Heron
    Pat Sacco
    Advances in Therapy, 2012, 29 : 148 - 162
  • [2] Cognitive Impairment Associated with Schizophrenia: The Humanistic and Economic Burden
    Rofail, Diana
    Kitchen, Helen
    Heyes, Anne
    Heron, Louise
    Sacco, Pat
    ANNALS OF NEUROLOGY, 2010, 68 (04) : S13 - S13
  • [3] B-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review
    Chung, Jun Ku
    Nakajima, Shinichiro
    Plitman, Eric
    Iwata, Yusuke
    Uy, Danielle
    Gerretsen, Philip
    Caravaggio, Fernando
    Chakravarty, M. Mallar
    Graff-Guerrero, Ariel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (10): : 923 - 939
  • [4] Humanistic burden in schizophrenia: A literature review
    Millier, A.
    Schmidt, U.
    Angermeyer, M. C.
    Chauhan, D.
    Murthy, V.
    Toumi, M.
    Cadi-Soussi, N.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 54 : 85 - 93
  • [5] TARGETED LITERATURE REVIEW (TLR) OF THE ECONOMIC BURDEN OF COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS)
    McGovern, A.
    English, M.
    Tongbram, V
    VALUE IN HEALTH, 2019, 22 : S688 - S688
  • [6] Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
    Joshi, Yash B.
    Thomas, Michael L.
    Braff, David L.
    Green, Michael F.
    Gur, Ruben C.
    Gur, Raquel E.
    Nuechterlein, Keith H.
    Stone, William S.
    Greenwood, Tiffany A.
    Lazzeroni, Laura C.
    MacDonald, Laura R.
    Molina, Juan L.
    Nungaray, John A.
    Radant, Allen D.
    Silverman, Jeremy M.
    Sprock, Joyce
    Sugar, Catherine A.
    Tsuang, Debby W.
    Tsuang, Ming T.
    Turetsky, Bruce, I
    Swerdlow, Neal R.
    Light, Gregory A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (09): : 838 - 847
  • [7] Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review
    Zoupa, Elli
    Bogiatzidou, Olympia
    Siokas, Vasileios
    Liampas, Ioannis
    Tzeferakos, Georgios
    Mavreas, Venetsanos
    Stylianidis, Stelios
    Dardiotis, Efthimios
    NEUROLOGY INTERNATIONAL, 2023, 15 (01): : 12 - 23
  • [8] A REVIEW OF INSTRUMENTS ASSESSING FUNCTIONAL OUTCOMES OF COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA
    Zhao, Yang
    Bowman, Lee
    Matza, Louis
    Prasad, Manishi
    QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1535 - 1535
  • [9] Atrial Fibrillation and Cognitive Impairment: An Associated Burden or Burden by Association?
    Manolis, Theodora A.
    Manolis, Antonis A.
    Apostolopoulos, Evdoxia J.
    Melita, Helen
    Manolis, Antonis S.
    ANGIOLOGY, 2020, 71 (06) : 498 - 519
  • [10] Is quality of life associated with cognitive impairment in schizophrenia?
    Alptekin, K
    Akvardar, Y
    Akdede, BBK
    Dumlu, K
    Isik, D
    Pirinçci, F
    Yahssin, S
    Kitis, A
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02): : 239 - 244